CoChat

MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in patients with AML

Open access
Heuser, Michael, Argiropoulos, Bob, Kuchenbauer, Florian, Yung, Eric, Piper, Jessica, Fung, Stephen, Schlenk, Richard F., Dohner, Konstanze, Hinrichsen, Tanja, Rudolph, Cornelia, Schambach, Axel, Baum, Christopher, Schlegelberger, Brigitte, Dohner, Hartmut, Ganser, Arnold, Humphries, R. Keith · 2007 · Blood
Cited by 148

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Overexpression of wild-type MN1 is a negative prognostic factor in patients with acute myeloid leukemia (AML) with normal cytogenetics. We evaluated whether MN1 plays a functional role in leukemogenesis. We demonstrate using retroviral gene transfer and bone marrow (BM) transplantation that MN1 overexpression rapidly induces lethal AML in mice. Insertional mutagenesis and chromosomal instability were ruled out as secondary aberrations. MN1 increased resistance to all-trans retinoic acid (ATRA)–induced cell-cycle arrest and differentiation by more than 3000-fold in vitro. The differentiation block could be released by fusion of a transcriptional activator (VP16) to MN1 without affecting the ability to immortalize BM cells, suggesting that MN1 blocks differentiation by transcriptional repression. We then evaluated whether MN1 expression levels in patients with AML (excluding M3-AML) correlated with resistance to ATRA treatment in elderly patients uniformly treated within treatment protocol AMLHD98-B. Strikingly, patients with low MN1 expression who received ATRA had a significantly prolonged event-free (P = .008) and overall (P = .04) survival compared with patients with either low MN1 expression and no ATRA, or high MN1 expression with or without ATRA. MN1 is a unique oncogene in hematopoiesis that both promotes proliferation/self-renewal and blocks differentiation, and may become useful as a predictive marker in AML treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood-2007-03-080523

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 148

Metadata

Authors
Heuser, M., Argiropoulos, B., Kuchenbauer, F., Yung, E., Piper, J., Fung, S., Schlenk, R. F., Dohner, K., Hinrichsen, T., Rudolph, C., Schambach, A., Baum, C., Schlegelberger, B., Dohner, H., Ganser, A., & Humphries, R. K.
Venue
Blood
Published
2007-09-01
Volume
110
Issue
5
Pages
1639-1647
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2043874839
Cited by
148
References
9
FWCI
6.81
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in patients with AML. https://app.cochat.ai/papers/10.1182/blood-2007-03-080523
The paper
Heuser, M., Argiropoulos, B., Kuchenbauer, F., Yung, E., Piper, J., Fung, S., Schlenk, R. F., Dohner, K., Hinrichsen, T., Rudolph, C., Schambach, A., Baum, C., Schlegelberger, B., Dohner, H., Ganser, A., & Humphries, R. K. (2007). MN1 overexpression induces acute myeloid leukemia in mice and predicts ATRA resistance in patients with AML. Blood. https://doi.org/10.1182/blood-2007-03-080523

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.